Rezultati pretraživanja
  1. prije 20 sati

    možda je završio, ali dok inovativnim metodama liječenja ne pobijedimo rak na dobrobit svih oboljelih!

  2. zeigt: Große Fortschritte im Kampf gegen - aber auch rund 50% mehr Erkrankungen als vor 25 Jahren. Krebs geht uns alle an. Und Krebs lässt sich nur besiegen, wenn wir gemeinsam all unsere Möglichkeiten in und Versorgung nutzen.

  3. 3. velj

    Millions of people wouldn't be here today if it wasn't for life-changing science. New treatments are helping cancer patients live life to the full after treatment & enjoy life’s simple moments

  4. 3. velj

    Znanstveni napredak je besmislen ako ne dolazi do onih kojima život ovisi o tome. Predano radimo sa svim dionicima kako bismo nadišli barijere koje utječu na dostupnost pravovremene i suvremene skrbi bolesnicima.

  5. 3. velj

    The number of potential years of working life lost due to cancer in Europe has decreased since 1995. until everyone in Europe who is touched by cancer, can look forward with hope and optimism

  6. 3. velj

    Significant variance in patient outcomes occurs across Europe: more needs to be done to ensure equity of access to treatment for patients across Europe

  7. 3. velj

    Spending on cancer has doubled since the mid-90s driven by demographic changes & improvements in cancer care. However, its overall share of the total health budget has remained stable over the past 20 years

  8. 31. sij

    Cancer mortality in children has decreased by 50% since 1995. driving innovation to help children stay healthy, so they can play, go to school and live their childhood to the fullest

  9. 31. sij

    Scientific advances are meaningless if they don’t reach the patients who need them. We are working with stakeholders to overcome barriers that could prevent patient access

  10. 30. sij

    Not every patient in Europe benefits in the same way. Europe needs to put greater focus on cancer to drive change towards better outcomes in cancer for citizens and patients

  11. 30. sij

    13,296 more lung cancer patients are alive for at least 5 years following a diagnosis in 2014, compared to those diagnosed in 2004. as we continue to invest in R&D to beat cancer

  12. 29. sij

    Tackling cancer: what would you hope to achieve in 5 years? - Decreased mortality rates in all European countries - Improved quality of life for people living with cancer Antonella Cardone

  13. 29. sij

    Tackling cancer: What would you hope to achieve in 5 years? Cohesion and a more collaborative approach towards our shared goal of improving patients' lives, says Alexander Roediger

  14. 29. sij

    Martin Seychell : The main problem is inequality. But inequalities mean that some countries are doing better than others. We should identify best practices to bring everyone to the highest level

  15. 29. sij

    Martin Seychell - we must look at both prevention, early detection, access to treatment and societal issues. Inequalities is high on the agenda, and better use of data. We need to move to an outcomes-based approach.

  16. 29. sij

    In some countries, only 20% of approved medicines are available to patients. More needs to be done to ensure equity of access to treatment for patients across Europe, says Alexander Roediger

  17. 29. sij

    The pharmaceutical industry invested €8.5 billion into cancer research in 2015, leading to an increase in the number of cancer medicines and indications over recent years ➡️

  18. 29. sij

    The pharmaceutical industry is driving increased R&D in oncology, leading to more treatments becoming available

  19. 29. sij

    All countries spend between 4-7% of total health expenditure on cancer care Link to the ➡️

  20. 29. sij

    Cancer mortality going up overall due to ageing population, but decreasing strongly in younger populations

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.